Triple antithrombotic therapy: risky but sometimes necessary.
Department of Cardiology, Copenhagen University Hospital Bispebjerg, Copenhagen, Denmark. Electronic address: rs@heart.dk.
Rikke
R
Sørensen
Department of Cardiology, Copenhagen University Hospital Bispebjerg, Copenhagen, Denmark.
Gunnar
G
Gislason
D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D001562:Benzimidazoles / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D000077144:Clopidogrel; D000069604:Dabigatran; D004359:Drug Therapy, Combination; D006801:Humans; D009025:Morpholines / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D000068799:Prasugrel Hydrochloride; D011720:Pyrazoles / Q000627:therapeutic use; D011728:Pyridones / Q000627:therapeutic use; D000069552:Rivaroxaban; D013876:Thiophenes / Q000627:therapeutic use; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D014812:Vitamin K / Q000037:antagonists & inhibitors; D015091:beta-Alanine / Q000031:analogs & derivatives / Q000627:therapeutic use
D000925:Anticoagulants; D001562:Benzimidazoles; D009025:Morpholines; D010879:Piperazines; D010975:Platelet Aggregation Inhibitors; D011720:Pyrazoles; D011728:Pyridones; D013876:Thiophenes; D015091:beta-Alanine; D014812:Vitamin K; C522181:apixaban; D000069552:Rivaroxaban; D000077144:Clopidogrel; D000068799:Prasugrel Hydrochloride; D000069604:Dabigatran; D013988:Ticlopidine; D001241:Aspirin